GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.
Weight loss drugs: the promise and pitfalls
GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.
GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.
GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.